At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 170 enrolled
Drug / intervention
Broccoli Sprout-derived Beverage +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Broccoli Sprout Dose Response: Bioavailability and Effects on Air Pollutants
Johns Hopkins Bloomberg School of Public Health·interventional·Posted Jan 15, 2016·Updated May 1, 2019
In Brief
A Phase 2 clinical trial evaluating Broccoli Sprout-derived Beverage and Placebos for Environmental Carcinogenesis. Completed, enrolled 170 participants across 1 site.
Detailed Summary
This study will examine the extent to which lower doses of a broccoli-derived beverage enhance the detoxication of air pollutants excreted in urine as compared to an maximal dose shown to be effective previously.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnvironmental Carcinogenesis
CountriesChina
CollaboratorsQidong Liver Cancer Institute, National Cancer Institute (NCI)
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedJan 2016
Primary CompletionMar 2016
TodayJul 2026
First PostedJan 15, 2016
Enrollment StartJan 1, 2016
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.5 years ago
Interventions
Broccoli Sprout-derived Beveragedrug
Maximum, half and one-fifth doses of broccoli sprout-derived beverage compared to placebos.
Placebosdrug
Placebo as comparison to broccoli sprout-derived beverages